Barely Significant
← all phrases

“near-significant”

2,307 sentences · 2,307 papers · 5,465 search hits before verification · confirmed specimen

Listed by Otte et al. (2022)

In the literature

near-significantp = 0.04320.9× alphagold
Specifically, for time spent in the external zone, significant or near-significant differences were observed between the CUMS-vehicle and the CUMS-BerryL groups ( p = 0.0432), with near-significant trends noted for the CUMS-BerryH ( p = 0.0657), CUMS-BrahmiBerryL ( p = 0.0541), and CUMS-BrahmiBerryH ( p = 0.0589) groups.
near-significantP = 0.0450.9× alphagold
Statistically significant and near-significant predictors of the posterior wall CIMT progression rate included LDL peak time ( P = 0.045), HDL-C ( P = 0.001), HDL 2 -C ( P = 0.005), HDL 3 -C ( P = 0.003), VLDL-C ( P = 0.037), VLDL 1+2 -C ( P = 0.016), VLDL 3 -C ( P = 0.056), and TG ( P = 0.079).
near-significantP = 0.04630.9× alphagold
When these South Delta metrics were studied by pairwise simple correlation using Multivariate Procedures in JMP Version 11.1, significant or near-significant correlations were detected between acres of cotton and kg of pyrethroid/acre of harvested cropland ( n = 32, r = 0.3549, P = 0.0463), number of applications for plant bugs and year ( n = 32, r = 0.3252, P = 0.0694), and acres of cotton and year ( n = 32, r = −0.3553, P = 0.0460).
near-significantp = 0.0491.0× alphagold
GSEA revealed trends in amino acid metabolism: GSEA of RTN3 in PD showed upregulation of glycine, serine and threonine metabolism ( Supplementary Figure S2c ); GSEA of MAP4K3 showed near-significant enrichment of phenylalanine metabolism in both PD (normalized enrichment score [NES] = −1.40, p = 0.049) and CHB (NES = 1.34, p = 0.09), with opposite enrichment directions ( Supplementary Figure S2e,f ).
near-significantp ≤ 0.051.0× alphagold
Variables showing significant or near-significant associations ( p ≤ 0.05) were subsequently included in multivariate models to adjust for potential confounders, including adiposity indices (BMI SDS, WHR), biochemical markers of metabolic syndrome (HDL cholesterol, triglycerides, insulin), cranial radiotherapy exposure, and the number of pituitary deficiencies.
near-significantP = 0.0501.0× alphagold
Belimumab prevented mcBILAG flares to a greater extent than placebo in patients with positive anti-dsDNA levels (HR: 0.70; 95% CI: 0.50–0.98; P = 0.035) and with a near-significant separation in patients with baseline SLEDAI-2K ≥10 (HR: 0.71; 95% CI: 0.51–1.00; P = 0.050), whereas no difference was seen in their counter groups.